Blood and Marrow Transplant Foundations
Key Takeaways
- Blood and marrow transplant replaces or rescues hematopoiesis after conditioning therapy or immune-based graft effects.
- Autologous transplant uses the patient's own cells, while allogeneic transplant uses donor cells and carries graft-versus-host disease risk.
- Nursing care centers on infection prevention, cytopenia management, mucositis care, nutrition, fluid balance, organ toxicity surveillance, and education.
- Engraftment, relapse risk, immune reconstitution, and late effects shape recovery and follow-up.
- Transplant patients need clear instructions for fever, medications, central line care, vaccination timing, and long-term survivorship needs.
Blood and Marrow Transplant Foundations
Blood and marrow transplant, also called hematopoietic cell transplant, is used for selected hematologic malignancies and some nonmalignant disorders. The procedure involves collecting hematopoietic stem cells, giving conditioning therapy when indicated, infusing cells, and supporting the patient while marrow function recovers or donor immune effects develop. Transplant is not a single day of treatment. It is a high-risk trajectory that includes evaluation, conditioning, cell infusion, cytopenic nadir, engraftment, discharge preparation, frequent monitoring, and long-term follow-up.
Major transplant types
| Type | Cell source | Key concept | Nursing emphasis |
|---|---|---|---|
| Autologous | Patient's own cells | Marrow rescue after high-dose therapy | Infection, mucositis, cytopenias, relapse teaching |
| Allogeneic | Related, unrelated, or cord donor cells | Donor immune system may attack cancer and host tissue | GVHD, immunosuppression, infection prevention |
| Reduced intensity allogeneic | Donor cells after less intensive conditioning | Relies more on graft-versus-tumor effect | Mixed chimerism, delayed effects, infection risk |
Conditioning may include chemotherapy, radiation, immunotherapy, or combinations. Goals include disease control, immune suppression for donor engraftment, and marrow space creation depending on transplant type. The RN reinforces the plan, assesses tolerance, administers supportive medications per orders, and watches for toxicities such as mucositis, nausea, vomiting, diarrhea, hemorrhagic cystitis, renal or hepatic dysfunction, pulmonary symptoms, cardiac changes, neurotoxicity, and severe fatigue.
Cell infusion and early recovery
Stem cell infusion may look similar to a blood product infusion, but patients and families often experience it as a major milestone. Nurses verify patient identity, product information, premedications, emergency readiness, vital signs, and central line patency according to policy. Some cryopreserved products contain dimethyl sulfoxide, which can cause a distinctive odor, nausea, flushing, throat irritation, bradycardia, hypertension, hypotension, or rare reactions. The nurse monitors closely and reports changes promptly.
After conditioning, the patient usually enters a nadir with neutropenia, anemia, and thrombocytopenia. Infection prevention is central. Fever in neutropenia is urgent even if the patient appears well. Nursing assessment includes temperature trends, chills, line site changes, cough, dyspnea, oral lesions, urinary symptoms, abdominal pain, diarrhea, skin lesions, mental status, and hemodynamic status. Thrombocytopenia assessment includes epistaxis, petechiae, bruising, gum bleeding, hematuria, melena, headache, and vision or neurologic changes.
Anemia assessment includes dyspnea, dizziness, chest discomfort, fatigue, and activity tolerance.
Engraftment and complications
Engraftment means donor or rescued stem cells are producing blood cells. The timing depends on graft source and transplant type. Rising neutrophil counts are encouraging, but recovery is not complete. Immune reconstitution takes much longer, especially after allogeneic transplant and ongoing immunosuppression.
Allogeneic transplant introduces graft-versus-host disease, or GVHD, in which donor immune cells attack recipient tissues. Acute GVHD often affects skin, liver, and gastrointestinal tract, with rash, bilirubin elevation, nausea, vomiting, anorexia, abdominal pain, or diarrhea. Chronic GVHD may affect skin, eyes, mouth, lungs, liver, fascia, joints, genital tissue, and quality of life. Nurses teach patients to report rash, new diarrhea, jaundice, dry eyes, oral sensitivity, skin tightening, cough, shortness of breath, or decreased range of motion.
Other important complications include sinusoidal obstruction syndrome, transplant-associated thrombotic microangiopathy, idiopathic pneumonia syndrome, fungal or viral infections, central line infection, relapse, infertility, endocrine dysfunction, bone loss, secondary malignancy, cognitive changes, and psychosocial distress. The RN does not diagnose these conditions independently, but trend recognition and escalation are essential.
Discharge and long-term teaching
Discharge after transplant requires practical readiness. Patients need to know who to call, which symptoms are urgent, how to take complex medications, how to care for the central line if present, how to protect against infection, and how to return for frequent labs and visits. Medication teaching often includes antimicrobial prophylaxis, immunosuppressants, antiemetics, electrolyte supplements, and symptom medicines. Nurses should assess access, affordability, pill organization, swallowing ability, caregiver support, and health literacy.
Common teaching points include:
- Report fever exactly as instructed; do not mask fever without guidance.
- Avoid sick contacts and follow food safety and hand hygiene instructions.
- Take immunosuppressants consistently and do not stop abruptly.
- Report diarrhea, rash, jaundice, cough, dyspnea, bleeding, confusion, or decreased intake.
- Follow revaccination and survivorship schedules from the transplant team.
Documentation should capture symptom assessment, line status, intake and output concerns, mucositis grade if used locally, transfusion response, education, caregiver participation, barriers, and handoff needs. Transplant nursing requires vigilance over time. The patient's counts may recover before stamina, immunity, nutrition, sexuality, fertility concerns, employment, and emotional recovery stabilize.
Which statement best distinguishes allogeneic transplant from autologous transplant?
A post-transplant patient with neutropenia reports a temperature that meets the center's fever threshold. What is the nurse's priority action?
Which symptom cluster is most concerning for possible acute graft-versus-host disease after allogeneic transplant?